Related Experiment Video
Updated: Aug 17, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
[Histiocytosis X discovered after chemotherapy treatment for mesothelioma]
Jessica Hendrick1, Olivier Golinval1, Renaud Louis1
1Service de Pneumologie, CHU Liège, Belgique.
Abstract:
Langerhans cell histiocytosis is a rare disorder characterized by clonal proliferation of Langerhans cells. We report the case of a 40-year-old active smoker who was initially treated for a right pleural mesothelioma with chemo-immunotherapy, bullectomy with talc pleurodesis, and subsequent pleuropneumonectomy due to extensive pleuro-pulmonary involvement. During an oncological reassessment, multiple nodular lesions were detected in the contralateral lung parenchyma and were initially suspected to be metastatic. However, histological analysis of bronchoalveolar lavage and transbronchial biopsies revealed pulmonary Langerhans cell histiocytosis (formerly known as eosinophilic granuloma or histiocytosis X). This case highlights the importance of differential diagnosis in post-treatment oncologic follow-up, particularly in smokers.

